Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disorders

References

• Hurley MN, McKeever TM, Prayle AP, et al. Rate of improvement of CF life expectancy exceeds that of general population–observational death registration study. J Cyst Fibros. 2014;13(4):410–415.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Classification of Cystic Fibrosis and Related Disorders. Report of a joint WHO/ICF(M)A-ECFTN meeting Reprinted in J Cyst Fibros 2001. 2002;1:5–8.
   Google Scholar
• Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245(4922):1073–1080.
   PubMed Web of Science ®Google Scholar
• Welsh MJRB, Accurso F, Cutting GR. Cystic fibrosis. In: Scriver CR, Ba, Sly WS, et al., Edited by. Metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2013.
   Google Scholar
• Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73(7):1251–1254.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Schrijver I. Cystic fibrosis: a review of associated phenotypes, use of molecular diagnostic approaches, genetic characteristics, progress, and dilemmas. J Mol Diagn. 2016;18(1):3–14.
   PubMed Web of Science ®Google Scholar
• Pier GB. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci U S A. 2000;97(16):8822–8828.
   PubMed Web of Science ®Google Scholar
• Konstan MW, Hilliard KA, Norvell TM, et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994;150(2):448–454.
   PubMed Web of Science ®Google Scholar
• Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153(2):S4–S14.
   PubMed Web of Science ®Google Scholar
• Cystic Fibrosis Foundation Patient Registry 2014 Annual Data Report. Cystic Fibrosis Foundation, Bethesda, Maryland, 2014;
   Google Scholar
• Dodge JA, Lewis PA, Stanton M, et al. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007;29(3):522–526.
   PubMed Web of Science ®Google Scholar
• Farrell PM, Lai HJ, Li Z, et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr. 2005;147(3 Suppl):S30–6.
   PubMed Web of Science ®Google Scholar
• Dankert-Roelse JE, Merelle ME. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr. 2005;147(3 Suppl):S15–20.
   PubMed Web of Science ®Google Scholar
• Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J Pediatr. 2005;147(3 Suppl):S11–4.
   PubMed Web of Science ®Google Scholar
• Accurso FJ, Sontag MK, Wagener JS. Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr. 2005;147(3 Suppl):S37–41.
   PubMed Web of Science ®Google Scholar
• Palomaki GE, Haddow JE, Bradley LA, et al. Updated assessment cystic fibrosis mutation frequencies in non-Hispanic Caucasians. Genet Med. 2002;4(2):90–94.
   PubMed Web of Science ®Google Scholar
• Parad RB, Comeau AM. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J Pediatr. 2005;147(3 Suppl):S78–82.
   PubMed Web of Science ®Google Scholar
• De Boeck K, Wilschanski M, Castellani C, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax. 2006;61(7):627–635.
   PubMed Web of Science ®Google Scholar
• Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7(5):450–453.
   PubMed Web of Science ®Google Scholar
• Goss CH, Rosenfeld M. Update on cystic fibrosis epidemiology. Curr Opin Pulm Med. 2004;10(6):510–514.
   PubMed Web of Science ®Google Scholar
• Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med. 2003;9(6):498–503.
   PubMed Web of Science ®Google Scholar
• Fanen P, Wohlhuter-Haddad A, Hinzpeter A. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies. Int J Biochem Cell Biol. 2014;52:94–102.
   PubMed Web of Science ®Google Scholar
• Bombieri C, Claustres M, De Boeck K, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros. 2011;10(Suppl 2):S86–102.
   PubMed Web of Science ®Google Scholar
• Ooi CY, Dupuis A, Ellis L, et al. Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language? Thorax. 2012;67(7):618–624.
   PubMed Web of Science ®Google Scholar
• Claustres M. Molecular pathology of the CFTR locus in male infertility. Reprod Biomed Online. 2005;10(1):14–41.
   PubMed Web of Science ®Google Scholar
• Kelly T, Buxbaum J. Gastrointestinal Manifestations of Cystic Fibrosis. Dig Dis Sci. 2015;60(7):1903–1913.
   PubMed Web of Science ®Google Scholar
• Shields MD, Levison H, Reisman JJ, et al. Appendicitis in cystic fibrosis. Arch Dis Child. 1991;66(3):307–310.
   PubMed Web of Science ®Google Scholar
• Chaudry G, Navarro OM, Levine DS, et al. Abdominal manifestations of cystic fibrosis in children. Pediatr Radiol. 2006;36(3):233–240.
   PubMed Web of Science ®Google Scholar
• Colombo C, Battezzati PM, Crosignani A, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology. 2002;36(6):1374–1382.
   PubMed Web of Science ®Google Scholar
• Ooi CY, Durie PR. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. J Cyst Fibros. 2012;11(5):355–362.
   PubMed Web of Science ®Google Scholar
• Habib AR, Buxton JA, Singer J, et al. Association between chronic rhinosinusitis and health-related quality of life in adults with Cystic Fibrosis. Ann Am Thorac Soc. 2015;12(8):1163–1169.
   PubMedGoogle Scholar
• Mainz JG, Koitschev A. Pathogenesis and management of nasal polyposis in cystic fibrosis. Curr Allergy Asthma Rep. 2012;12(2):163–174.
   Web of Science ®Google Scholar
• Sly PD, Gangell CL, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med. 2013;368(21):1963–1970.
   PubMed Web of Science ®Google Scholar
• Morgan WJ, Butler SM, Johnson CA, et al. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol. 1999;28(4):231–241.
   PubMed Web of Science ®Google Scholar
• Berkhout MC, van Rooden CJ, Rijntjes E, et al. Sinonasal manifestations of cystic fibrosis: a correlation between genotype and phenotype? J Cyst Fibros. 2014;13(4):442–448.
   PubMed Web of Science ®Google Scholar
• Derichs N. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis. Eur Respir Rev. 2013;22(127):58–65.
   PubMedGoogle Scholar
• Ratjen F. Restoring airway surface liquid in cystic fibrosis. N Engl J Med. 2006;354(3):291–293.
   PubMed Web of Science ®Google Scholar
• Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959;23(3):545–549.
   PubMed Web of Science ®Google Scholar
• Quinton P, Molyneux L, Ip W, et al. beta-adrenergic sweat secretion as a diagnostic test for cystic fibrosis. Am J Respir Crit Care Med. 2012;186(8):732–739.
   PubMed Web of Science ®Google Scholar
• Guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK, Report from the Multidisciplinary Working Group. Association of Clinical Biochemistry, 2002
   Google Scholar
• Rosenstein BJ. Diagnostic methods. In: Hodson M GD, ed. London: Cystic fibrosis. Arnold Publishers. 2000.
   Google Scholar
• LeGrys VA, Applequist R, Briscoe DR, et al. Sweat testing: sample collection and quantitative analysis, Approved guideline C34-A2. Wayne, PA, USA: National Committee for Clinical Laboratory Standards (NCCLS); 2000.
   Google Scholar
• Naehrlich L. Sweat testing practices in German cystic fibrosis centres. Klin Padiatr. 2007;219(2):70–73.
   PubMed Web of Science ®Google Scholar
• Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther. 1995;6(4):445–455.
   PubMed Web of Science ®Google Scholar
• Paranjape SM, Zeitlin PL. Atypical cystic fibrosis and CFTR-related diseases. Clin Rev Allergy Immunol. 2008;35(3):116–123.
   PubMed Web of Science ®Google Scholar
• Wilschanski M, Durie PR. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut. 2007;56(8):1153–1163.
   PubMed Web of Science ®Google Scholar
• Naehrlich L, Ballmann M, Davies J, et al. Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey. J Cyst Fibros. 2014;13(1):24–28.
   PubMed Web of Science ®Google Scholar
• Hallberg K, Reims A, Strandvik B. Electrogenic ion transport in duodenum, an aid in cystic fibrosis diagnosis. Scand J Gastroenterol. 2000;35(10):1106–1109.
   PubMed Web of Science ®Google Scholar
• Veeze HJ, Sinaasappel M, Bijman J, et al. Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis. Gastroenterology. 1991;101(2):398–403.
   PubMed Web of Science ®Google Scholar
• Mall M, Hirtz S, Gonska T, et al. Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis. J Cyst Fibros. 2004;3(Suppl 2):165–169.
   PubMedGoogle Scholar
• Crossley JR, Smith PA, Edgar BW, et al. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots. Clin Chim Acta. 1981;113(2):111–121.
   PubMed Web of Science ®Google Scholar
• Castellani C, Southern KW, Brownlee K, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 2009;8(3):153–173.
   PubMed Web of Science ®Google Scholar
• Mayell SJ, Munck A, Craig JV, et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros. 2009;8(1):71–78.
   PubMed Web of Science ®Google Scholar
• Sosnay PR, Siklosi KR, Van Goor F, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013;45(10):1160–1167.
   PubMed Web of Science ®Google Scholar
• Corvol H, Thompson KE, Tabary O, et al. Translating the genetics of cystic fibrosis to personalized medicine. Transl Res. 2016;168:40–49.
   PubMed Web of Science ®Google Scholar
• Bell SC, De Boeck K, Amaral MD. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol Ther. 2015;145:19–34.
   PubMed Web of Science ®Google Scholar
• Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361(9358):681–689.
   PubMed Web of Science ®Google Scholar
• Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001;183(3):444–452.
   PubMed Web of Science ®Google Scholar
• Hartl D, Latzin P, Hordijk P, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med. 2007;13(12):1423–1430.
   PubMed Web of Science ®Google Scholar
• Hoiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005;4(Suppl 2):49–54.
   PubMedGoogle Scholar
• Taccetti G, Campana S, Festini F, et al. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J. 2005;26(3):458–461.
   PubMed Web of Science ®Google Scholar
• Campodonico VL, Gadjeva M, Paradis-Bleau C, et al. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol Med. 2008;14(3):120–133.
   PubMed Web of Science ®Google Scholar
• Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32(4):277–287.
   PubMed Web of Science ®Google Scholar
• Mainz JG, Koitschev A. Management of chronic rhinosinusitis in CF. J Cyst Fibros. 2009;8(Suppl 1):S10–4.
   PubMedGoogle Scholar
• Kopelman H, Durie P, Gaskin K, et al. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med. 1985;312(6):329–334.
   PubMed Web of Science ®Google Scholar
• Fried MD, Durie PR, Tsui LC, et al. The cystic fibrosis gene and resting energy expenditure. J Pediatr. 1991;119(6):913–916.
   PubMed Web of Science ®Google Scholar
• O’Riordan SM, Robinson PD, Donaghue KC, et al. Management of cystic fibrosis-related diabetes. Pediatr Diabetes. 2008;9(4 Pt 1):338–344.
   PubMed Web of Science ®Google Scholar
• Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care. 2005;28(9):2141–2144.
   PubMed Web of Science ®Google Scholar
• Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999;30(5):1151–1158.
   PubMed Web of Science ®Google Scholar
• Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med. 2007;13(6):529–536.
   PubMed Web of Science ®Google Scholar
• Kopito LE, Kosasky HJ, Shwachman H. Water and electrolytes in cervical mucus from patients with cystic fibrosis. Fertil Steril. 1973;24(7):512–516.
   PubMed Web of Science ®Google Scholar
• Dodge JA. Male fertility in cystic fibrosis. Lancet. 1995;346(8975):587–588.
   PubMed Web of Science ®Google Scholar
• Stewart B, Zabner J, Shuber AP, et al. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med. 1995;151(3 Pt 1):899–903.
   PubMed Web of Science ®Google Scholar
• Leoni GB, Pitzalis S, Podda R, et al. A specific cystic fibrosis mutation (T3381) associated with the phenotype of isolated hypotonic dehydration. J Pediatr. 1995;127(2):281–283.
   PubMed Web of Science ®Google Scholar
• Augarten A, Kerem BS, Yahav Y, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C–>T mutation. Lancet. 1993;342(8862):25–26.
   PubMed Web of Science ®Google Scholar
• Romano L, Minicucci L, Schiaffino MC, et al. Uncommon presenting manifestations of cystic fibrosis: a clinical alert. Padiatr Padol. 1995;30(1):1–7.
   Google Scholar
• Kerem E. Atypical CF and CF related diseases. Paediatr Respir Rev. 2006;7(Suppl 1):S144–6.
   PubMed Web of Science ®Google Scholar
• Gan KH, Geus WP, Bakker W, et al. Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years. Thorax. 1995;50(12):1301–1304.
   PubMed Web of Science ®Google Scholar
• Voter KZ, Ren CL. Diagnosis of cystic fibrosis. Clin Rev Allergy Immunol. 2008;35(3):100–106.
   PubMed Web of Science ®Google Scholar
• Ziedalski TM, Kao PN, Henig NR, et al. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest. 2006;130(4):995–1002.
   PubMed Web of Science ®Google Scholar
• Mainz J, Hammer U, Rokahr C, et al. Cystic fibrosis in 65- and 67-year-old siblings. clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G–>A. Respiration. 2006;73(5):698–704.
   PubMed Web of Science ®Google Scholar
• Michl RK, Mentzel HJ, Gerber A, et al. A patient nicknamed ‘saline’: atypical course with cystic fibrosis. Klin Padiatr. 2013;225(5):288–289.
   PubMed Web of Science ®Google Scholar
• Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr. 1998;132(4):589–595.
   PubMed Web of Science ®Google Scholar
• Kerem E, Conway S, Elborn S, et al. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005;4(1):7–26.
   PubMedGoogle Scholar
• Button BM, Wilson C, Dentice R, et al. Physiotherapy for cystic fibrosis in Australia and New Zealand: a clinical practice guideline. Respirology. 2016;21(4):656–667.
   PubMed Web of Science ®Google Scholar
• Hanrahan JW, Sampson HM, Thomas DY. Novel pharmacological strategies to treat cystic fibrosis. Trends Pharmacol Sci. 2013;34(2):119–125.
   PubMed Web of Science ®Google Scholar
• Clancy JP, Jain M. Personalized medicine in cystic fibrosis: dawning of a new era. Am J Respir Crit Care Med. 2012;186(7):593–597.
   PubMed Web of Science ®Google Scholar
• Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365(18):1663–1672.
   PubMed Web of Science ®Google Scholar
• Davies JC, Wainwright CE, Canny GJ, et al. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. Am J Respir Crit Care Med. 2013;187(11):1219–1225.
   PubMed Web of Science ®Google Scholar
• Wainwright CE, Elborn JS, Ramsey BW. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med. 2015;373(18):1783–1784.
   PubMed Web of Science ®Google Scholar
• Kerem E, Konstan MW, De Boeck K, et al. Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med. 2014;2(7):539–547.
   PubMed Web of Science ®Google Scholar
• Scotet V, de Braekeleer M, Roussey M, et al. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years’ experience and impact on prenatal diagnosis. Lancet. 2000;356(9232):789–794.
   PubMed Web of Science ®Google Scholar
• Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med. 1997;337(14):963–969.
   PubMed Web of Science ®Google Scholar
• Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107(1):1–13.
   PubMed Web of Science ®Google Scholar
• Konstan MW, Morgan WJ, Butler SM, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr. 2007;151(2):134–9, 39 e1.
   PubMed Web of Science ®Google Scholar
• Padman R, McColley SA, Miller DP, et al. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics. 2007;119(3):e531–7.
   PubMed Web of Science ®Google Scholar
• McKay KO, Waters DL, Gaskin KJ. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales. J Pediatr. 2005;147(3 Suppl):S47–50.
   PubMed Web of Science ®Google Scholar
• Farrell PM, Shen G, Splaingard M, et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics. 1997;100(5):E2.
   PubMed Web of Science ®Google Scholar
• Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol. 1996;22(6):387–395.
   PubMed Web of Science ®Google Scholar
• Collaco JM, Blackman SM, McGready J, et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157(5):802-7 e1-3.
   PubMed Web of Science ®Google Scholar
• Corvol H, Blackman SM, Boelle PY, et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun. 2015;6:8382.
   PubMed Web of Science ®Google Scholar